Boston Scientific
- Mapping and Ablation
- Venous Therapies
- Cardiac Rhythm Management
- Structural Heart
- Interventional Oncology
- Drug-Eluting Technologies
- Coronary
Playback speed
10 seconds
EMBLEM™ S-ICD: What We’ve Learned From 100,000 Patients
254 views
June 13, 2022
Professor Pier Lambiase and Dr. Reinoud Knops review clinical trial data and make the case for why S-ICD should be considered in more diverse patient populations.
Comments 0
Login to view comments.
Click here to Login
Cardiac Rhythm Management
Wed, Sep 22, 2021
Faculty: Camille Frazier-Mills , Marat Fudim , Boston Scientific , Adrian Hernandez
Faculty: Camille Frazier-Mills , Marat Fudim , Boston Scientific , Adrian Hernandez